Your browser doesn't support javascript.
loading
Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population.
Dimeglio, Chloé; Trémeaux, Pauline; Herin, Fabrice; Da-Silva, Isabelle; Porcheron, Marion; Martin-Blondel, Guillaume; Gernigon, Caroline; Chapuy-Regaud, Sabine; Villars, Hélène; Izopet, Jacques.
Afiliação
  • Dimeglio C; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France; INSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France. Electronic address: dimeglio.c@chu-toulouse.fr.
  • Trémeaux P; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France; INSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France.
  • Herin F; Occupational Diseases Department, Toulouse University Hospital, 31000 Toulouse, France; Inserm UMR 1295: Center for research in population health (CERPOP)- Department of Epidemiology and Public Health, Toulouse. University of Toulouse III F-31073, 37, allées Jules Guesde, 31073 Toulouse, France.
  • Da-Silva I; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France.
  • Porcheron M; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France.
  • Martin-Blondel G; INSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France; Infectious and Tropical Diseases Department, Toulouse University Hospital, 31300 Toulouse, France.
  • Gernigon C; Occupational Diseases Department, Toulouse University Hospital, 31000 Toulouse, France; Inserm UMR 1295: Center for research in population health (CERPOP)- Department of Epidemiology and Public Health, Toulouse. University of Toulouse III F-31073, 37, allées Jules Guesde, 31073 Toulouse, France.
  • Chapuy-Regaud S; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France.
  • Villars H; Inserm UMR 1295: Center for research in population health (CERPOP)- Department of Epidemiology and Public Health, Toulouse. University of Toulouse III F-31073, 37, allées Jules Guesde, 31073 Toulouse, France; CHU Toulouse (Toulouse University Hospital) Geriatric Department, Hôpital Purpan Pavillon L
  • Izopet J; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France; INSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France.
J Infect ; 85(6): 702-769, 2022 12.
Article em En | MEDLINE | ID: mdl-36064047

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article